Almac Clinical Services, a subsidiary of Almac Group, has introduced its Tempod 1000 that is claimed to enhance the company's Site Compliance and temperature management offering for sponsors, it was reported on Wednesday.
Intended to augment Almac's established temperature management service, Tempod 1000 is a USB device that captures and stores all clinical site temperature data and automatically finds unreported excursions once uploaded into TempEZ. It is aimed at removing the administrative burden of updating manual temperature logs, increasing site compliance with reporting data and promoting best digital practice in clinical studies and patient safety.
The device will also decrease the risk of missed patient visits due to unreported excursions, enable sponsors and CRAs to identify and resolve excursions remotely, accelerates CRA review time during site visits, and facilitate timely and efficient study close-outs and database locks.
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics
Saluda Medical secures CE certification for EVA Sensing Technology in Europe